| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $630.6M | +21.5% |
| Cost of Revenue | $247.9M | +29.5% |
| Gross Profit | $382.7M | +16.9% |
| R&D Expense | $130.6M | +35.2% |
| SG&A Expense | $102.5M | +16.3% |
| Operating Income | -$76.1M | -70.7% |
| Interest Expense | $9.9M | -66.1% |
| Pre-tax Income | -$88.9M | -12.5% |
| Income Tax | $11.4M | +61.5% |
| Net Income | -$100.3M | -16.5% |
| EPS (Basic) | -$0.21 | -5.0% |
| EPS (Diluted) | -$0.21 | -5.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $99.1M | -21.7% |
| Short-term Investments | $40.9M | +7506.9% |
| Accounts Receivable | $120.4M | +7.2% |
| Current Assets | $305.7M | +7.2% |
| Total Assets | $2.27B | -1.7% |
| Current Liabilities | $401.7M | +12.0% |
| Long-term Debt | $205.2M | -21.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $124.1M | +1.6% |
| Capital Expenditures | $6.9M | +47.4% |
| Investing Cash Flow | -$106.3M | -74.7% |
| Financing Cash Flow | -$39.9M | -1486.6% |
| Free Cash Flow | $117.2M | -0.2% |
| Total Liabilities |
| $655.1M |
| -3.2% |
| Stockholders' Equity | $1.61B | -1.1% |